Page 4 - Wilmot Cancer Institute | UR Medicine
P. 4

ReseaRch PRogRams of exceLLence



            The Wilmot Cancer Institute has long set the standard for excellence in cancer care in our community and beyond. We will focus on what is essential to improve future care—growing our research programs. Our talented researchers
            and clinicians will focus on three key research programs: the hallmarks of cancer, immunotherapy, and cancer control and survivorship.






             HALLMARKS OF CANCER



             Each of us has a unique genetic makeup—and sometimes
             a genetic susceptibility to cancer. Instead of focusing
             on single mutations within each cancer subtype, our
             scientists are searching for the molecular flaws many
             cancers have in common. We believe these common
             hallmarks hold the key to future treatments. We envision a
             day, for example, when cancer will be diagnosed through
             its genetic features instead of an association to the
             pancreas, lung, breast, or another organ. Meanwhile, we
             search databases for current, approved drugs that might
             target these genetic abnormalities. We work to discover
             affordable precision treatments that disrupt core functions
             of cancer—offering personalized medicine that can be
             applied to broad groups of people, striking cancer in new
             and more effective ways.




             CANCER CONTROL AND
             SURVIVORSHIP


             Thanks to significant research advances in the past decade,
             there are nearly 15.5 million cancer survivors—and the
             numbers grow every day. Survivorship will grow to more
             than 20 million by 2026. The Wilmot Cancer Institute has
             a rich history in cancer survivorship research deepening
             our understanding of the risks of second cancers after
             treatment, post-treatment brain fog, sleep disorders, and
             nausea. We are now looking at specific ways to reduce the
             side effects of chemotherapy and radiation, and developing
             personalized models to predict who will benefit most from
             various therapies.
   1   2   3   4   5   6